Evidence of T2/T3 Endotype Overlap in Mild-to-Severe Asthma with Chronic Rhinosinusitis: A Pilot Study
@atscommunity.bsky.social #medsky
π tinyurl.com/5cb44spc
28.02.2026 01:47 β
π 2
π 0
π¬ 0
π 0
Developing a Model of Health and Supportive Care for People with Silicosis in Australia
@atscommunity.bsky.social #medsky
π tinyurl.com/5x4kxy6h
26.02.2026 17:13 β
π 2
π 0
π¬ 0
π 0
Prognostic Significance of Peripheral Blood Monocyte Count Among a National Cohort of Veterans with Pulmonary Fibrosis
@atscommunity.bsky.social #medsky
π tinyurl.com/54nkkpp2
25.02.2026 21:33 β
π 4
π 3
π¬ 0
π 0
Long-Term Air Pollution Exposure, Plant-based Diet, and Asthma Exacerbations in the Nursesβ Health Study II
@atscommunity.bsky.social #medsky
π tinyurl.com/4mbpzy4j
24.02.2026 21:46 β
π 2
π 0
π¬ 0
π 0
Toward equity in recovery after critical illness
@atscommunity.bsky.social #medsky
π tinyurl.com/49n9acny
24.02.2026 00:23 β
π 1
π 0
π¬ 0
π 0
More acetaminophen or less opioids to reduce delirium in the intensive care unit
@atscommunity.bsky.social #medsky
π Open Access
π tinyurl.com/emnfhwcx
20.02.2026 20:11 β
π 2
π 0
π¬ 1
π 0
New exposure, ancient disease: patient experiences with artificial stone silicosis
@atscommunity.bsky.social #medsky
π tinyurl.com/mrd696e7
19.02.2026 17:22 β
π 2
π 0
π¬ 0
π 0
Can what we eat protect us from what we breathe? Air pollution, plant-based diets, and asthma
@atscommunity.bsky.social #medsky
π Open Access
π tinyurl.com/5fdktj2y
18.02.2026 19:11 β
π 5
π 0
π¬ 0
π 0
ATS International Committee Chair Jennifer L. Taylor, MD, MSCS, ATSF explains that #ATS2026 has training sessions & networking with colleagues. Watch the ATS Breathe Easy podcast: youtu.be/sRdoQM40jJQ
Register for ATS 2026 by March 12 to save! registration.experientevent.com/ShowATS261/F...
17.02.2026 19:33 β
π 1
π 5
π¬ 0
π 0
History and future outlook for the US Clean Air Act
@atscommunity.bsky.social #medsky
π tinyurl.com/2x9tzdx5
17.02.2026 20:18 β
π 3
π 1
π¬ 0
π 0
Privacy and dignity for undocumented people? Cliniciansβ duties and responses to patient immigration status inquiries
@atscommunity.bsky.social #medsky
π tinyurl.com/48ptx7w4
12.02.2026 19:02 β
π 2
π 0
π¬ 0
π 0
The clinical, psychosocial, and economic burden of cystic fibrosis lung disease in the era of CFTR modulator therapy
@atscommunity.bsky.social #medsky
π tinyurl.com/53jm3z3v
11.02.2026 18:35 β
π 1
π 0
π¬ 0
π 0
A βPalliPulmβ framework to improve palliative care education and practice in pulmonaryβcritical care medicine: an official American Thoracic Society Workshop Report
@atscommunity.bsky.social
π academic.oup.com/annalsats/ar...
10.02.2026 17:11 β
π 6
π 3
π¬ 0
π 2
The latest issue of the #AnnalsATS is now live!
Take a look: academic.oup.com/annalsats/is...
@atscommunity.bsky.social #medsky
09.02.2026 15:58 β
π 3
π 1
π¬ 0
π 0
When it comes to respiratory health, early abnormalities should be taken seriously. As Anna Podolanczuk, MD, explains on the ATS Breathe Easy podcast, early intervention could help patient outcomes with it comes to interstitial lung disease.
Watch now: youtu.be/S7-_yt76M_k
03.02.2026 16:30 β
π 2
π 5
π¬ 0
π 0
π£ Wed, Jan 28th at 11am ET!
26.01.2026 22:13 β
π 2
π 0
π¬ 0
π 0
Advance articles | Annals of the American Thoracic Society | Oxford Academic
π£ We are pleased to inform you that all accepted ahead-of-print articles are now available at academic.oup.com/annalsats/ad...
@atscommunity.bsky.social #medsky
23.01.2026 14:34 β
π 2
π 1
π¬ 0
π 0
π£The ATS Steering Committee on Advancement & Learning (SCALe) has opportunities for ATS members to grow your network. Apply to strengthen your #professionaldevelopment and shape future educational initiatives at the ATS.π₯ΌDeadline: 5 p.m. ET, Jan. 28 1οΈβ£/2οΈβ£8οΈβ£
Apply now: site.thoracic.org/learning/ste...
22.01.2026 17:00 β
π 0
π 4
π¬ 0
π 0
AnnalsATS is excited to announce Dr. Christopher Goss as our new Editor-in-Chief!
Please join us in welcoming Dr. Goss. Full bio here: www.atsjournals.org/announcement...?
22.01.2026 15:51 β
π 4
π 0
π¬ 0
π 0
π HIGHLIGHTING ANNALS ATS MOST-READ ARTICLES OF 2025
Intermittent versus Daily Therapy for Noncavitary Mycobacterium avium Complex Pulmonary Disease: An Open-Label Randomized Trial
@atscommunity.bsky.social
π tinyurl.com/mpkvkh3e
21.01.2026 17:33 β
π 2
π 1
π¬ 0
π 0
π HIGHLIGHTING ANNALS ATS MOST-READ ARTICLES OF 2025
Impact of Heat on Respiratory Hospitalizations among Older Adults in 120 Large U.S. Urban Areas
@atscommunity.bsky.social #medsky
π tinyurl.com/4trrj6x7
20.01.2026 17:01 β
π 1
π 0
π¬ 0
π 0
Does Every Person with Asthma Need an Inhaled Corticosteroid? | Annals of the American Thoracic Society
π HIGHLIGHTING ANNALS ATS MOST-READ ARTICLES OF 2025
Does Every Person with Asthma Need an Inhaled Corticosteroid?
@atscommunity.bsky.social #medsky
π tinyurl.com/54jmzp98
16.01.2026 16:45 β
π 1
π 0
π¬ 0
π 0
Early registration for #ATS2026 is open!
Register here: site.thoracic.org/myats/update...
15.01.2026 19:04 β
π 1
π 0
π¬ 0
π 1
π HIGHLIGHTING ANNALS ATS MOST-READ ARTICLES OF 2025
Research Priorities for Noninvasive Sampling of the Lower Respiratory Tract during Acute Respiratory Failure: An Official American Thoracic Society Workshop Report
@atscommunity.bsky.social #medsky
π tinyurl.com/ms223xf8
15.01.2026 18:33 β
π 2
π 0
π¬ 0
π 0
Climate Change and Respiratory Health: Opportunities to Contribute to Environmental Justice: An Official American Thoracic Society Workshop Report | Annals of the American Thoracic Society
Climate Change, Respiratory Health Effects, and Inequities
π HIGHLIGHTING ANNALS ATS MOST-READ ARTICLES OF 2025
Climate Change and Respiratory Health: Opportunities to Contribute to Environmental Justice: An Official American Thoracic Society Workshop Report
@atscommunity.bsky.social #medsky
π tinyurl.com/46t6phsr
14.01.2026 15:47 β
π 2
π 1
π¬ 0
π 0
What role do federal agencies play in your day-to-day life? As Nicholas Nassikas, MD, explains, federal agencies affect your public health while at work and at home, and cuts to them could be disastrous. Learn more on this episode of the ATS Breathe Easy podcast.
Watch now: youtu.be/naK6B12a4P8
13.01.2026 16:34 β
π 0
π 6
π¬ 0
π 0
Comprehensive Management Algorithm for Mycobacterium avium Complex Pulmonary Disease in the Real-World Setting | Annals of the American Thoracic Society
The management of Mycobacterium avium complex pulmonary disease (MAC-PD) is challenging because of limited efficacy and frequent adverse events associated with standard treatments. The 2020 guidelines from the American Thoracic Society, European Respiratory Society, European Society of Clinical Microbiology and Infectious Diseases, and Infectious Diseases Society of America provide recommendations, but real-world adherence is often hindered by these issues, leading many patients to be unable to complete standard therapy. This review proposes a comprehensive management algorithm for MAC-PD, emphasizing multidisciplinary approaches and integrating nonantimicrobial management before, during, and after drug treatment to enhance patient outcomes. When a patient presents with chronic respiratory symptoms suggestive of nontuberculous mycobacteria, clinicians should follow a guideline-based approach to diagnosis, as diagnostic delays are common because of nonspecific symptoms. Proper evaluation should determine the disease phenotype (existence of cavitary lesions), as it influences treatment choices. Airway clearance, nutritional support, and management of underlying conditions are essential nonantimicrobial components. Regular outpatient monitoring helps detect disease progression and optimize treatment. Treatment strategies vary based on disease severity. For noncavitary nodular bronchiectatic disease, a thrice-weekly regimen is preferred because of better tolerability. Severe cases or those with cavitary forms may require daily treatment with additional aminoglycosides. Amikacin liposome inhalation suspension is recommended for patients not responding to standard regimens after 6 months. Recent research addresses drug intolerance, suggesting alternatives such as a two-drug regimen without rifamycin in certain cases. Consultation with nontuberculous mycobacteria specialists is advised for complex cases, particularly those with macrolide resistance or requiring surgical intervention. The algorithm emphasizes shared decision making, patient education, and family support to improve adherence and outcomes.
π HIGHLIGHTING ANNALS ATS MOST-READ ARTICLES OF 2025
Comprehensive Management Algorithm for Mycobacterium avium Complex Pulmonary Disease in the Real-World Setting
@atscommunity.bsky.social #medsky
π tinyurl.com/2u845twd
13.01.2026 16:46 β
π 2
π 1
π¬ 0
π 0
The Great Controversy of Obstructive Sleep Apnea Treatment for Cardiovascular Risk Benefit: Advancing the Science through Expert Consensus: An Official American Thoracic Society Workshop Report | Anna...
π HIGHLIGHTING ANNALS ATS MOST-READ ARTICLES OF 2025
The Great Controversy of Obstructive Sleep Apnea Treatment for Cardiovascular Risk Benefit: Advancing the Science through Expert Consensus: An Official American Thoracic Society Workshop Report
#medsky
π tinyurl.com/24jzk4ju
12.01.2026 15:40 β
π 0
π 0
π¬ 0
π 0
